ArticleArchives of microbiology2026
Multi-target molecular mechanisms of Cymbopogon flexuosus essential oil reveal membrane destabilization, ROS-mediated cellular damage, efflux perturbation, biofilm suppression and resistance-target interference in Staphylococcus aureus.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The rapid emergence of antibiotic-resistant Staphylococcus aureus necessitates exploring alternative antimicrobial agents with multi-target mechanisms of action. In the present study, the antibacterial efficacy and mechanistic activity of 21 essential oils were investigated against S. aureus using integrated microbiological, biochemical, flow cytometric, microscopic, and computational approaches. Preliminary screening through disc diffusion, MIC, and MBC assays identified Cymbopogon flexuosus, Cymbopogon nardus, and Eucalyptus hybrida as the most active essential oils, with C. flexuosus exhibiting the strongest antibacterial potency. Percentage inhibition assays, growth kinetics, confirmed concentration-dependent antibacterial activity, with C. flexuosus and C. nardus producing > 60% inhibition and rapid growth suppression within 2 h at MIC and 2×MIC. Mechanistic investigations revealed that C. flexuosus essential oil induced significant membrane destabilization, as evidenced by the crystal violet permeability assay, as they increase relative permeability 58.2% at twice MIC, increased nucleic acid and protein leakage, increased propidium iodide permeability, and elevated ethidium bromide accumulation, indicating membrane disruption and perturbation of efflux pumps. Scanning electron microscopy further confirmed severe morphological alterations, including membrane collapse and cellular deformation. In addition, intracellular reactive oxygen species (ROS) generation increased significantly following treatment, suggesting oxidative stress-mediated bacterial killing. C. flexuosus also demonstrated potent antibiofilm activity, reducing biofilm formation by more than 60% at the MIC and twice the MIC in S. aureus. GC-MS analysis identified geranial, neral, citronellal, geraniol, limonene, and β-caryophyllene as major volatile constituents. Molecular docking studies revealed favourable interactions between several compounds and critical bacterial targets involved in cell wall biosynthesis and antibiotic resistance, including β-lactamases and penicillin-binding proteins. Furthermore, in silico ADMET profiling suggested that the selected constituents possess favourable physicochemical and safety properties for topical therapeutic applications. These findings demonstrate that C. flexuosus essential oil exerts potent anti-staphylococcal activity through multiple mechanisms, including membrane destabilisation, ROS-mediated cellular damage, efflux perturbation, biofilm suppression, and interference with resistance targets. The study highlights the therapeutic potential of C. flexuosus essential oil as a promising natural antibacterial candidate against S. aureus infections.
Indexed as
Identifiers
42667397What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.